Quvium Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • (Upcoming)
  • Latest Deal Amount
  • $4.2M
Latest Deal Amount
  • Investors
  • 6

Quvium General Information

Description

Developer of a medical device designed to assist people with chronic and acute respiratory conditions. The company's device which is a wearable cough monitor predict and prevent attacks or flare-ups, reducing emergency room visits, hospitalizations and even deaths, enabling asthma sufferers as well as cystic fibrosis patients and people with chronic obstructive pulmonary disease get access to better treatment and enhanced medical care.

Contact Information

Formerly Known As
Asthma Signals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Monitoring Equipment
Primary Office
  • C/o Quvium UK
  • Unit 4/5 Invicta Way, Manston Park, Ramsgate, Kent, Sandwich
  • Ramsgate CT12 5FD
  • England, United Kingdom
+44 01304 000000

Quvium Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Quvium Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) $4.2M Upcoming Generating Revenue
5. Later Stage VC 05-Apr-2019 00000 00.00 00.00 Completed Generating Revenue
4. Early Stage VC 11-Dec-2017 00000 00.000 00.000 Completed Generating Revenue
3. Grant 03-Nov-2017 00000 00.000 Completed Generating Revenue
2. Early Stage VC 23-Nov-2016 $1.68M $1.68M 00.000 Completed Generating Revenue
1. Equity Crowdfunding 22-Jun-2015 $400K 00.000 Completed Generating Revenue
To view Quvium’s complete valuation and funding history, request access »

Quvium Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 79,700 $0.000001 $4.12 $4.12 1x $4.12 5.01%
Ordinary 81,600 $0.000001 $4.85 $4.85 1x $4.85 5.13%
To view Quvium’s complete cap table history, request access »

Quvium Executive Team (3)

Name Title Board Seat Contact Info
Steven Schmidt Co-Founder, Chief Executive Officer & Board Member
Thomas Smith Co-Founder & President
Karen Travers Co-Founder & CCO
To view Quvium’s complete executive team members history, request access »

Quvium Board Members (11)

Name Representing Role Since
Christopher Hare Quvium Board Member 000 0000
Gill Inman Quvium Board Member 000 0000
Jack Porter Quvium Board Member 000 0000
Mark Murcko Ph.D Self Board Member 000 0000
Peng Wu Quvium Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Quvium Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GrowthInvest Angel Group Minority 000 0000 000000 0
NCL Technology Ventures Venture Capital Minority 000 0000 000000 0
Vala Capital Venture Capital Minority 000 0000 000000 0
Creative England Venture Capital Minority 000 0000 000000 0
Expansion East Kent Other 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »